Page last updated: 2024-08-24

simendan and Deafness, Transitory

simendan has been researched along with Deafness, Transitory in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Askin, S; Ekinci Akdemir, FN; Eser, G; Gozeler, MS; Sahin, A; Yildirim, S	1

Other Studies

1 other study(ies) available for simendan and Deafness, Transitory

Article	Year
Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model. International journal of pediatric otorhinolaryngology, 2019, Volume: 122 Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cisplatin; Cochlea; Deoxyguanosine; Disease Models, Animal; Female; Glutathione Peroxidase; Hearing; Hearing Loss; Malondialdehyde; Otoacoustic Emissions, Spontaneous; Oxidative Stress; Phosphodiesterase 3 Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Signal-To-Noise Ratio; Simendan; Superoxide Dismutase	2019

Article

Year

Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.

International journal of pediatric otorhinolaryngology, 2019, Volume: 122

Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cisplatin; Cochlea; Deoxyguanosine; Disease Models, Animal; Female; Glutathione Peroxidase; Hearing; Hearing Loss; Malondialdehyde; Otoacoustic Emissions, Spontaneous; Oxidative Stress; Phosphodiesterase 3 Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Signal-To-Noise Ratio; Simendan; Superoxide Dismutase

2019